nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2C8—Colchicine—primary biliary cirrhosis	0.152	0.344	CbGbCtD
Irbesartan—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.122	0.276	CbGbCtD
Irbesartan—CYP2C9—Colchicine—primary biliary cirrhosis	0.106	0.24	CbGbCtD
Irbesartan—CYP3A4—Colchicine—primary biliary cirrhosis	0.0618	0.14	CbGbCtD
Irbesartan—Heartburn—Chenodeoxycholic acid—primary biliary cirrhosis	0.00361	0.0109	CcSEcCtD
Irbesartan—Olmesartan—ABCC2—primary biliary cirrhosis	0.00329	0.485	CrCbGaD
Irbesartan—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00312	0.00948	CcSEcCtD
Irbesartan—Gout—Colchicine—primary biliary cirrhosis	0.00296	0.00898	CcSEcCtD
Irbesartan—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00812	CcSEcCtD
Irbesartan—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00268	0.00812	CcSEcCtD
Irbesartan—Aplastic anaemia—Colchicine—primary biliary cirrhosis	0.00259	0.00787	CcSEcCtD
Irbesartan—Bone pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00259	0.00787	CcSEcCtD
Irbesartan—Bone pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00259	0.00787	CcSEcCtD
Irbesartan—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00763	CcSEcCtD
Irbesartan—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00763	CcSEcCtD
Irbesartan—Hepatic function abnormal—Colchicine—primary biliary cirrhosis	0.0023	0.00697	CcSEcCtD
Irbesartan—Oesophagitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00689	CcSEcCtD
Irbesartan—Oesophagitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00689	CcSEcCtD
Irbesartan—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00681	CcSEcCtD
Irbesartan—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00224	0.00681	CcSEcCtD
Irbesartan—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00632	CcSEcCtD
Irbesartan—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00632	CcSEcCtD
Irbesartan—Hepatic function abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00626	CcSEcCtD
Irbesartan—Hepatic function abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00626	CcSEcCtD
Irbesartan—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00623	CcSEcCtD
Irbesartan—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00623	CcSEcCtD
Irbesartan—Haemolytic anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.002	0.00606	CcSEcCtD
Irbesartan—Haemolytic anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.002	0.00606	CcSEcCtD
Irbesartan—Injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00196	0.00595	CcSEcCtD
Irbesartan—Injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00196	0.00595	CcSEcCtD
Irbesartan—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00575	CcSEcCtD
Irbesartan—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00189	0.00575	CcSEcCtD
Irbesartan—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00563	CcSEcCtD
Irbesartan—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00563	CcSEcCtD
Irbesartan—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00558	CcSEcCtD
Irbesartan—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00558	CcSEcCtD
Irbesartan—Cramp muscle—Colchicine—primary biliary cirrhosis	0.00181	0.00548	CcSEcCtD
Irbesartan—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00177	0.00537	CcSEcCtD
Irbesartan—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00528	CcSEcCtD
Irbesartan—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00528	CcSEcCtD
Irbesartan—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00505	CcSEcCtD
Irbesartan—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.00505	CcSEcCtD
Irbesartan—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.005	CcSEcCtD
Irbesartan—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.005	CcSEcCtD
Irbesartan—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.005	CcSEcCtD
Irbesartan—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.005	CcSEcCtD
Irbesartan—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00494	CcSEcCtD
Irbesartan—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00494	CcSEcCtD
Irbesartan—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00493	CcSEcCtD
Irbesartan—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00493	CcSEcCtD
Irbesartan—Neutropenia—Colchicine—primary biliary cirrhosis	0.00162	0.00492	CcSEcCtD
Irbesartan—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00473	CcSEcCtD
Irbesartan—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00473	CcSEcCtD
Irbesartan—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00473	CcSEcCtD
Irbesartan—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00473	CcSEcCtD
Irbesartan—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00473	CcSEcCtD
Irbesartan—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00473	CcSEcCtD
Irbesartan—Losartan—ACE—primary biliary cirrhosis	0.00155	0.229	CrCbGaD
Irbesartan—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00464	CcSEcCtD
Irbesartan—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00464	CcSEcCtD
Irbesartan—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00461	CcSEcCtD
Irbesartan—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00461	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00439	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00439	CcSEcCtD
Irbesartan—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.00144	0.00438	CcSEcCtD
Irbesartan—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00432	CcSEcCtD
Irbesartan—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00432	CcSEcCtD
Irbesartan—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.0043	CcSEcCtD
Irbesartan—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.0043	CcSEcCtD
Irbesartan—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00424	CcSEcCtD
Irbesartan—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00424	CcSEcCtD
Irbesartan—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00138	0.00419	CcSEcCtD
Irbesartan—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00416	CcSEcCtD
Irbesartan—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00416	CcSEcCtD
Irbesartan—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00414	CcSEcCtD
Irbesartan—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00414	CcSEcCtD
Irbesartan—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00413	CcSEcCtD
Irbesartan—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00413	CcSEcCtD
Irbesartan—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00411	CcSEcCtD
Irbesartan—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00411	CcSEcCtD
Irbesartan—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.0041	CcSEcCtD
Irbesartan—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.0041	CcSEcCtD
Irbesartan—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.0041	CcSEcCtD
Irbesartan—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.0041	CcSEcCtD
Irbesartan—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00399	CcSEcCtD
Irbesartan—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00399	CcSEcCtD
Irbesartan—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00398	CcSEcCtD
Irbesartan—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00131	0.00398	CcSEcCtD
Irbesartan—Valsartan—ALB—primary biliary cirrhosis	0.0013	0.192	CrCbGaD
Irbesartan—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00125	0.0038	CcSEcCtD
Irbesartan—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00379	CcSEcCtD
Irbesartan—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00379	CcSEcCtD
Irbesartan—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00376	CcSEcCtD
Irbesartan—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00376	CcSEcCtD
Irbesartan—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00374	CcSEcCtD
Irbesartan—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00374	CcSEcCtD
Irbesartan—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00373	CcSEcCtD
Irbesartan—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00373	CcSEcCtD
Irbesartan—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00372	CcSEcCtD
Irbesartan—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00372	CcSEcCtD
Irbesartan—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00371	CcSEcCtD
Irbesartan—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00371	CcSEcCtD
Irbesartan—Malnutrition—Colchicine—primary biliary cirrhosis	0.00121	0.00367	CcSEcCtD
Irbesartan—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00365	CcSEcCtD
Irbesartan—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00365	CcSEcCtD
Irbesartan—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00353	CcSEcCtD
Irbesartan—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00353	CcSEcCtD
Irbesartan—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00116	0.00352	CcSEcCtD
Irbesartan—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00351	CcSEcCtD
Irbesartan—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00351	CcSEcCtD
Irbesartan—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00343	CcSEcCtD
Irbesartan—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00343	CcSEcCtD
Irbesartan—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00342	CcSEcCtD
Irbesartan—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00342	CcSEcCtD
Irbesartan—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00341	CcSEcCtD
Irbesartan—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00341	CcSEcCtD
Irbesartan—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00112	0.0034	CcSEcCtD
Irbesartan—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00112	0.0034	CcSEcCtD
Irbesartan—Anaemia—Colchicine—primary biliary cirrhosis	0.00112	0.00339	CcSEcCtD
Irbesartan—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00338	CcSEcCtD
Irbesartan—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.00338	CcSEcCtD
Irbesartan—Angioedema—Colchicine—primary biliary cirrhosis	0.0011	0.00335	CcSEcCtD
Irbesartan—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00329	CcSEcCtD
Irbesartan—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00329	CcSEcCtD
Irbesartan—Leukopenia—Colchicine—primary biliary cirrhosis	0.00108	0.00328	CcSEcCtD
Irbesartan—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00325	CcSEcCtD
Irbesartan—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00325	CcSEcCtD
Irbesartan—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00106	0.00323	CcSEcCtD
Irbesartan—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00106	0.00323	CcSEcCtD
Irbesartan—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.0032	CcSEcCtD
Irbesartan—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.0032	CcSEcCtD
Irbesartan—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00317	CcSEcCtD
Irbesartan—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00317	CcSEcCtD
Irbesartan—Arthralgia—Colchicine—primary biliary cirrhosis	0.00103	0.00312	CcSEcCtD
Irbesartan—Myalgia—Colchicine—primary biliary cirrhosis	0.00103	0.00312	CcSEcCtD
Irbesartan—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00306	CcSEcCtD
Irbesartan—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00306	CcSEcCtD
Irbesartan—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.001	0.00304	CcSEcCtD
Irbesartan—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.001	0.00304	CcSEcCtD
Irbesartan—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000992	0.00301	CcSEcCtD
Irbesartan—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000992	0.00301	CcSEcCtD
Irbesartan—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000979	0.00297	CcSEcCtD
Irbesartan—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000979	0.00297	CcSEcCtD
Irbesartan—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000975	0.00296	CcSEcCtD
Irbesartan—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000975	0.00296	CcSEcCtD
Irbesartan—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000973	0.00295	CcSEcCtD
Irbesartan—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000973	0.00295	CcSEcCtD
Irbesartan—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000971	0.00295	CcSEcCtD
Irbesartan—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000971	0.00295	CcSEcCtD
Irbesartan—Shock—Colchicine—primary biliary cirrhosis	0.00097	0.00294	CcSEcCtD
Irbesartan—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000967	0.00293	CcSEcCtD
Irbesartan—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000965	0.00293	CcSEcCtD
Irbesartan—Skin disorder—Colchicine—primary biliary cirrhosis	0.000958	0.00291	CcSEcCtD
Irbesartan—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000954	0.0029	CcSEcCtD
Irbesartan—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000954	0.0029	CcSEcCtD
Irbesartan—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000947	0.00287	CcSEcCtD
Irbesartan—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000947	0.00287	CcSEcCtD
Irbesartan—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000937	0.00284	CcSEcCtD
Irbesartan—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000937	0.00284	CcSEcCtD
Irbesartan—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000924	0.0028	CcSEcCtD
Irbesartan—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000924	0.0028	CcSEcCtD
Irbesartan—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000924	0.0028	CcSEcCtD
Irbesartan—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000924	0.0028	CcSEcCtD
Irbesartan—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000924	0.0028	CcSEcCtD
Irbesartan—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000924	0.0028	CcSEcCtD
Irbesartan—Hypotension—Colchicine—primary biliary cirrhosis	0.000921	0.0028	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000918	0.00279	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000918	0.00279	CcSEcCtD
Irbesartan—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000913	0.00277	CcSEcCtD
Irbesartan—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000913	0.00277	CcSEcCtD
Irbesartan—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000904	0.00274	CcSEcCtD
Irbesartan—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000904	0.00274	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000898	0.00273	CcSEcCtD
Irbesartan—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000886	0.00269	CcSEcCtD
Irbesartan—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000886	0.00269	CcSEcCtD
Irbesartan—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00088	0.00267	CcSEcCtD
Irbesartan—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00088	0.00267	CcSEcCtD
Irbesartan—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000871	0.00265	CcSEcCtD
Irbesartan—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000871	0.00265	CcSEcCtD
Irbesartan—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000869	0.00264	CcSEcCtD
Irbesartan—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000869	0.00264	CcSEcCtD
Irbesartan—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000867	0.00263	CcSEcCtD
Irbesartan—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000867	0.00263	CcSEcCtD
Irbesartan—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000864	0.00262	CcSEcCtD
Irbesartan—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000864	0.00262	CcSEcCtD
Irbesartan—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00086	0.00261	CcSEcCtD
Irbesartan—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00086	0.00261	CcSEcCtD
Irbesartan—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000857	0.0026	CcSEcCtD
Irbesartan—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000856	0.0026	CcSEcCtD
Irbesartan—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000856	0.0026	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000851	0.00258	CcSEcCtD
Irbesartan—Fatigue—Colchicine—primary biliary cirrhosis	0.00085	0.00258	CcSEcCtD
Irbesartan—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000844	0.00256	CcSEcCtD
Irbesartan—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000844	0.00256	CcSEcCtD
Irbesartan—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000828	0.00251	CcSEcCtD
Irbesartan—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000828	0.00251	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000807	0.00245	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000807	0.00245	CcSEcCtD
Irbesartan—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000806	0.00245	CcSEcCtD
Irbesartan—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000795	0.00241	CcSEcCtD
Irbesartan—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000795	0.00241	CcSEcCtD
Irbesartan—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00079	0.0024	CcSEcCtD
Irbesartan—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00079	0.0024	CcSEcCtD
Irbesartan—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000787	0.00239	CcSEcCtD
Irbesartan—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000787	0.00239	CcSEcCtD
Irbesartan—Urticaria—Colchicine—primary biliary cirrhosis	0.000783	0.00238	CcSEcCtD
Irbesartan—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00078	0.00237	CcSEcCtD
Irbesartan—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00078	0.00237	CcSEcCtD
Irbesartan—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000779	0.00237	CcSEcCtD
Irbesartan—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00077	0.00234	CcSEcCtD
Irbesartan—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00077	0.00234	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000765	0.00232	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000765	0.00232	CcSEcCtD
Irbesartan—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00232	CcSEcCtD
Irbesartan—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000764	0.00232	CcSEcCtD
Irbesartan—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000757	0.0023	CcSEcCtD
Irbesartan—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000757	0.0023	CcSEcCtD
Irbesartan—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000757	0.0023	CcSEcCtD
Irbesartan—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000757	0.0023	CcSEcCtD
Irbesartan—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00222	CcSEcCtD
Irbesartan—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00222	CcSEcCtD
Irbesartan—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000726	0.0022	CcSEcCtD
Irbesartan—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000724	0.0022	CcSEcCtD
Irbesartan—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000724	0.0022	CcSEcCtD
Irbesartan—Asthenia—Colchicine—primary biliary cirrhosis	0.000707	0.00215	CcSEcCtD
Irbesartan—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000704	0.00214	CcSEcCtD
Irbesartan—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000704	0.00214	CcSEcCtD
Irbesartan—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0007	0.00213	CcSEcCtD
Irbesartan—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0007	0.00213	CcSEcCtD
Irbesartan—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0007	0.00213	CcSEcCtD
Irbesartan—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0007	0.00213	CcSEcCtD
Irbesartan—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000674	0.00205	CcSEcCtD
Irbesartan—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000653	0.00198	CcSEcCtD
Irbesartan—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000653	0.00198	CcSEcCtD
Irbesartan—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000635	0.00193	CcSEcCtD
Irbesartan—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000635	0.00193	CcSEcCtD
Irbesartan—Losartan—ALB—primary biliary cirrhosis	0.000635	0.0938	CrCbGaD
Irbesartan—Vomiting—Colchicine—primary biliary cirrhosis	0.000627	0.0019	CcSEcCtD
Irbesartan—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000627	0.0019	CcSEcCtD
Irbesartan—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000627	0.0019	CcSEcCtD
Irbesartan—Rash—Colchicine—primary biliary cirrhosis	0.000622	0.00189	CcSEcCtD
Irbesartan—Dermatitis—Colchicine—primary biliary cirrhosis	0.000621	0.00188	CcSEcCtD
Irbesartan—Headache—Colchicine—primary biliary cirrhosis	0.000618	0.00187	CcSEcCtD
Irbesartan—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00184	CcSEcCtD
Irbesartan—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000606	0.00184	CcSEcCtD
Irbesartan—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000586	0.00178	CcSEcCtD
Irbesartan—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000586	0.00178	CcSEcCtD
Irbesartan—Nausea—Colchicine—primary biliary cirrhosis	0.000586	0.00178	CcSEcCtD
Irbesartan—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00171	CcSEcCtD
Irbesartan—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00171	CcSEcCtD
Irbesartan—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000558	0.0017	CcSEcCtD
Irbesartan—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000558	0.0017	CcSEcCtD
Irbesartan—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00169	CcSEcCtD
Irbesartan—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00169	CcSEcCtD
Irbesartan—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000555	0.00168	CcSEcCtD
Irbesartan—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000555	0.00168	CcSEcCtD
Irbesartan—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000526	0.0016	CcSEcCtD
Irbesartan—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000526	0.0016	CcSEcCtD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—TYK2—primary biliary cirrhosis	0.000216	0.000977	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000215	0.000971	CbGpPWpGaD
Irbesartan—JUN—Immune System—SP100—primary biliary cirrhosis	0.000214	0.000967	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—NFKB1—primary biliary cirrhosis	0.000213	0.000963	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000211	0.000955	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000211	0.000955	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—primary biliary cirrhosis	0.000211	0.000955	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000209	0.000945	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000209	0.000945	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—NFKB1—primary biliary cirrhosis	0.000208	0.000938	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000207	0.000936	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ELMO1—primary biliary cirrhosis	0.000206	0.00093	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—MMP2—primary biliary cirrhosis	0.000203	0.000917	CbGpPWpGaD
Irbesartan—JUN—B Cell Receptor Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000203	0.000915	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	0.000201	0.000909	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—NFKB1—primary biliary cirrhosis	0.000199	0.0009	CbGpPWpGaD
Irbesartan—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000197	0.00089	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—OGDH—primary biliary cirrhosis	0.000196	0.000884	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000195	0.000879	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000193	0.000871	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—TYK2—primary biliary cirrhosis	0.000193	0.000871	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—CD80—primary biliary cirrhosis	0.00019	0.00086	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—NFKB1—primary biliary cirrhosis	0.00019	0.000859	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00019	0.000858	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—NFKB1—primary biliary cirrhosis	0.000185	0.000833	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000184	0.000831	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000182	0.000823	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.00018	0.000813	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—NFKB1—primary biliary cirrhosis	0.000179	0.00081	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000177	0.0008	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000177	0.000799	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PDHX—primary biliary cirrhosis	0.000174	0.000788	CbGpPWpGaD
Irbesartan—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	0.00017	0.000768	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—primary biliary cirrhosis	0.000169	0.000762	CbGpPWpGaD
Irbesartan—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000167	0.000754	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000166	0.000749	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ABCB4—primary biliary cirrhosis	0.000164	0.00074	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—DLAT—primary biliary cirrhosis	0.000164	0.00074	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000164	0.000739	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	0.000161	0.000726	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD3D—primary biliary cirrhosis	0.000158	0.000715	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000157	0.000711	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—HIF1A—primary biliary cirrhosis	0.000157	0.000707	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000154	0.000694	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	0.000153	0.00069	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—LBR—primary biliary cirrhosis	0.000152	0.000688	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—NFKB1—primary biliary cirrhosis	0.000152	0.000686	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—NFKB1—primary biliary cirrhosis	0.00015	0.000678	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	0.000148	0.000667	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL7R—primary biliary cirrhosis	0.000145	0.000657	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GGT1—primary biliary cirrhosis	0.000143	0.000646	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000143	0.000646	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000142	0.000642	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—NFKB1—primary biliary cirrhosis	0.000139	0.000629	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000139	0.000627	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000139	0.000627	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000139	0.000626	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAP3K14—primary biliary cirrhosis	0.000138	0.000623	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000134	0.000605	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000132	0.000598	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000131	0.00059	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000128	0.00058	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000126	0.000569	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	0.000125	0.000566	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000124	0.000558	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—NFKB1—primary biliary cirrhosis	0.00012	0.000544	CbGpPWpGaD
Irbesartan—JUN—Immune System—ELMO1—primary biliary cirrhosis	0.00012	0.000542	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TAB1—primary biliary cirrhosis	0.00012	0.000541	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.00012	0.00054	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000118	0.000532	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000117	0.00053	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	0.000116	0.000526	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	0.000115	0.000521	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000115	0.000519	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000112	0.000507	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—OGDH—primary biliary cirrhosis	0.00011	0.000498	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000109	0.000492	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000109	0.000492	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000109	0.00049	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000104	0.000469	CbGpPWpGaD
Irbesartan—JUN—Immune System—NUP210—primary biliary cirrhosis	0.000103	0.000464	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.0001	0.000452	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	9.95e-05	0.000449	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	9.94e-05	0.000449	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	9.89e-05	0.000447	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NUP210—primary biliary cirrhosis	9.85e-05	0.000445	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LBR—primary biliary cirrhosis	9.85e-05	0.000445	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PDHX—primary biliary cirrhosis	9.82e-05	0.000444	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDH5—primary biliary cirrhosis	9.59e-05	0.000433	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	9.38e-05	0.000424	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	9.32e-05	0.000421	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DLAT—primary biliary cirrhosis	9.23e-05	0.000417	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCB4—primary biliary cirrhosis	9.23e-05	0.000417	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCR5—primary biliary cirrhosis	9.23e-05	0.000417	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ABCG2—primary biliary cirrhosis	9.16e-05	0.000414	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—NFKB1—primary biliary cirrhosis	9.09e-05	0.000411	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—AGT—primary biliary cirrhosis	9.08e-05	0.00041	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MMP3—primary biliary cirrhosis	9.02e-05	0.000408	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCL5—primary biliary cirrhosis	8.52e-05	0.000385	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	8.5e-05	0.000384	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL9—primary biliary cirrhosis	8.38e-05	0.000379	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	8.08e-05	0.000365	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	8.01e-05	0.000362	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CTGF—primary biliary cirrhosis	7.86e-05	0.000355	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—AGT—primary biliary cirrhosis	7.85e-05	0.000354	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT2—primary biliary cirrhosis	7.79e-05	0.000352	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ELMO1—primary biliary cirrhosis	7.76e-05	0.00035	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	7.68e-05	0.000347	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	7.57e-05	0.000342	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.45e-05	0.000336	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTLA4—primary biliary cirrhosis	7.45e-05	0.000336	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD80—primary biliary cirrhosis	7.4e-05	0.000334	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—AGT—primary biliary cirrhosis	7.12e-05	0.000322	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—OGDH—primary biliary cirrhosis	7.12e-05	0.000321	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD79A—primary biliary cirrhosis	7.1e-05	0.000321	CbGpPWpGaD
Irbesartan—JUN—Immune System—TAB1—primary biliary cirrhosis	6.97e-05	0.000315	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	6.85e-05	0.000309	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP3—primary biliary cirrhosis	6.79e-05	0.000307	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.79e-05	0.000307	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT1—primary biliary cirrhosis	6.72e-05	0.000304	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT1—primary biliary cirrhosis	6.72e-05	0.000304	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	6.42e-05	0.00029	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL5—primary biliary cirrhosis	6.41e-05	0.00029	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PDHX—primary biliary cirrhosis	6.34e-05	0.000287	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TYK2—primary biliary cirrhosis	6.24e-05	0.000282	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.21e-05	0.000281	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PPARGC1A—primary biliary cirrhosis	5.98e-05	0.00027	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DLAT—primary biliary cirrhosis	5.96e-05	0.000269	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCB4—primary biliary cirrhosis	5.96e-05	0.000269	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	5.89e-05	0.000266	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.84e-05	0.000264	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	5.84e-05	0.000264	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	5.79e-05	0.000262	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—primary biliary cirrhosis	5.79e-05	0.000262	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NUP210—primary biliary cirrhosis	5.55e-05	0.000251	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.49e-05	0.000248	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.38e-05	0.000243	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AGT—primary biliary cirrhosis	5.36e-05	0.000242	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP3—primary biliary cirrhosis	5.33e-05	0.000241	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TYK2—primary biliary cirrhosis	5.33e-05	0.000241	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	5.28e-05	0.000239	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.23e-05	0.000236	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	5.21e-05	0.000235	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	5.16e-05	0.000233	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCG2—primary biliary cirrhosis	5.16e-05	0.000233	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL5—primary biliary cirrhosis	5.03e-05	0.000227	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	4.95e-05	0.000224	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	4.9e-05	0.000221	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	4.9e-05	0.000221	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.89e-05	0.000221	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.88e-05	0.00022	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NFKB1—primary biliary cirrhosis	4.87e-05	0.00022	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	4.85e-05	0.000219	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	4.85e-05	0.000219	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CD80—primary biliary cirrhosis	4.75e-05	0.000215	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AGT—primary biliary cirrhosis	4.66e-05	0.00021	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	4.52e-05	0.000204	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	4.47e-05	0.000202	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	4.47e-05	0.000202	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CTGF—primary biliary cirrhosis	4.43e-05	0.0002	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	4.41e-05	0.000199	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT2—primary biliary cirrhosis	4.39e-05	0.000198	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—primary biliary cirrhosis	4.37e-05	0.000197	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD80—primary biliary cirrhosis	4.31e-05	0.000195	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.22e-05	0.000191	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AGT—primary biliary cirrhosis	4.21e-05	0.00019	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	4.15e-05	0.000187	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	4.15e-05	0.000187	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TYK2—primary biliary cirrhosis	4.01e-05	0.000181	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP3—primary biliary cirrhosis	3.98e-05	0.00018	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.98e-05	0.00018	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	3.82e-05	0.000173	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.82e-05	0.000173	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.81e-05	0.000172	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT1—primary biliary cirrhosis	3.79e-05	0.000171	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT1—primary biliary cirrhosis	3.79e-05	0.000171	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL5—primary biliary cirrhosis	3.76e-05	0.00017	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CD80—primary biliary cirrhosis	3.73e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.64e-05	0.000165	CbGpPWpGaD
Irbesartan—JUN—Immune System—TYK2—primary biliary cirrhosis	3.64e-05	0.000164	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	3.58e-05	0.000162	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—primary biliary cirrhosis	3.58e-05	0.000162	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	3.41e-05	0.000154	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.4e-05	0.000154	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARGC1A—primary biliary cirrhosis	3.37e-05	0.000152	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	3.33e-05	0.000151	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	3.2e-05	0.000145	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	3.2e-05	0.000145	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—primary biliary cirrhosis	3.16e-05	0.000143	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.16e-05	0.000143	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.15e-05	0.000142	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AGT—primary biliary cirrhosis	3.14e-05	0.000142	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.13e-05	0.000141	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.1e-05	0.00014	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	2.94e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.92e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	2.92e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	2.86e-05	0.000129	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	2.83e-05	0.000128	CbGpPWpGaD
Irbesartan—JUN—Immune System—NFKB1—primary biliary cirrhosis	2.83e-05	0.000128	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CD80—primary biliary cirrhosis	2.79e-05	0.000126	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	2.74e-05	0.000124	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	2.71e-05	0.000122	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.65e-05	0.00012	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AGT—primary biliary cirrhosis	2.62e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	2.49e-05	0.000113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.48e-05	0.000112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.45e-05	0.000111	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	2.45e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	2.45e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.38e-05	0.000107	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TYK2—primary biliary cirrhosis	2.35e-05	0.000106	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	2.35e-05	0.000106	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	2.33e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	2.33e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	2.32e-05	0.000105	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	2.31e-05	0.000104	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	2.18e-05	9.83e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.03e-05	9.18e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—primary biliary cirrhosis	2.01e-05	9.1e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	2.01e-05	9.07e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	2.01e-05	9.07e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	1.99e-05	8.99e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	1.99e-05	8.99e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	1.99e-05	8.98e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	1.97e-05	8.9e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.92e-05	8.69e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—primary biliary cirrhosis	1.85e-05	8.36e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.83e-05	8.27e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.79e-05	8.08e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.79e-05	8.07e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	1.77e-05	8e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	1.7e-05	7.68e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	1.7e-05	7.68e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	1.7e-05	7.66e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.53e-05	6.93e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.52e-05	6.87e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.51e-05	6.84e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	1.39e-05	6.29e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	1.38e-05	6.23e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	1.31e-05	5.93e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	1.31e-05	5.93e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	1.3e-05	5.88e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	1.18e-05	5.33e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.17e-05	5.28e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	1.07e-05	4.82e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	1.06e-05	4.78e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	9.1e-06	4.11e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	9.05e-06	4.09e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	6.98e-06	3.15e-05	CbGpPWpGaD
